Hodgkin's disease: in vitro susceptibility of skin fibroblasts to infection with virus and to lysis by autologous lymphocytes. NLM AIDSLINE Important note: Information in this article was accurate in 1985. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Hodgkin's disease: in vitro susceptibility of skin fibroblasts to infection with virus and to lysis by autologous lymphocytes.

Tokai J Exp Clin Med. 1983 Dec;8(5-6):485-95. Unique Identifier : AIDSLINE MED/85219706
Ebbesen P; Olsson L; Vestergaard BF; Ting R; Haahr S

Abstract: Fibroblast cultures established from the skin of 16 untreated stage 1 and stage 2 Hodgkin's patients (HD) and 60 healthy controls were studied in their 3rd, 4th and 5th in vitro passage. HD cultures were similar to control cultures with respect to transformation with Simian sarcoma virus (SSV) and SV40 and with respect to interferon release. HD cultures, however, showed a depressed replication of both herpes simplex virus (HSV) type 1 and type 2. Preliminary evidence for enhanced immune interaction with fibroblasts in HD was a more frequent injury of HD than control fibroblast cultures when incubated 4 hours with autologous mononuclear leucocytes in the presence of autologous serum.
Keywords: Adolescence Adult Aged Cell Transformation, Viral Child Cytotoxicity, Immunologic Fibroblasts/MICROBIOLOGY Hodgkin's Disease/*IMMUNOLOGY/MICROBIOLOGY Human Interferons/SECRETION Lymphocytes/*IMMUNOLOGY Middle Age Sarcoma Viruses, Simian Simplexvirus Skin/*MICROBIOLOGY Support, Non-U.S. Gov't JOURNAL ARTICLE

KWDadolescenceadultagedcelltransformation,viralchildcytotoxicity,immunologicfibroblasts/microbiologyhodgkin'sdisease/KWDimmunology/microbiologyhumaninterferons/secretionlymphocytes/KWDimmunologymiddleagesarcomaviruses,simiansimplexvirusskin/KWDmicrobiologysupport,non-uKWDsKWDgov'tjournalarticle
850930
M8590150

Copyright © 1985 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1985. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1985. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .